Institutional investors hold a majority ownership of AMGN through the 83.39% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2014, these large investors purchased a net $3.5 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
STATE STREET GLOBAL ADVISORS LTD... Bought 910.1 Thousand shares of Amgen Inc
STRALEM & CO., INC. Bought 326.2 Thousand shares of Amgen Inc
FLOSSBACH VON STORCH AG Bought 251.3 Thousand shares of Amgen Inc